Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Efficacy and safety of dexamethasone nanoparticles eye drops in diabetic macular edema.

Trial Profile

Efficacy and safety of dexamethasone nanoparticles eye drops in diabetic macular edema.

Recruiting
Phase of Trial: Phase II

Latest Information Update: 08 Aug 2018

At a glance

  • Drugs Dexamethasone (Primary)
  • Indications Diabetic macular oedema
  • Focus Therapeutic Use
  • Sponsors Oculis Pharma
  • Most Recent Events

    • 09 May 2018 Planned End Date changed from 5 May 2018 to 9 Jan 2019.
    • 09 May 2018 Planned number of patients changed from 96 to 144.
    • 18 Jul 2017 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top